Questionnaire survey on malnutrition when encapsulating Enzarutamide, in collaborat on with a pharmacy dispensing pharmacy at Hakodate Municipal Hospital -Part2-
Phase of Trial: Phase IV
Latest Information Update: 27 Dec 2018
At a glance
- Drugs Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 23 Dec 2018 Planned End Date changed from 31 Dec 2018 to 30 Sep 2019.
- 14 Jun 2018 Status changed from not yet recruiting to recruiting.
- 05 Jan 2018 New trial record